SUCCESSFUL TREATMENT OF MYELOMA KIDNEY BY DIURESIS AND PLASMAPHORESIS
SUCCESSFUL TREATMENT OF MYELOMA KIDNEY BY DIURESIS AND PLASMAPHORESIS
复制标题
DOI:
10.1136/bmj.1.6008.503
复制
发表时间:
1976-01-01
影响因子:
--
通讯作者:
COHEN, SL
中科院分区:
文献类型:
--
作者:
FEEST, TG;BURGE, PS;COHEN, SL
DiscussionWhen acute renal failure occurs in myelomatosis the prognosis is poor: in one series 13 of 14 patients died within two months'. There is a strong correlation between the occurence of Bence Jones pro-teinuria and renal failure in myeloma. 1 2 The precise role of these proteins in the pathogenesis of renal failure is uncertain, but direct toxicity of light chains to the renal tubule, 3 and tubular obstruction by casts4 have both been postulated. It seems reasonable to treat myeloma kidney by attempting to remove Bence Jones proteins from the kidney, and to prevent reac-cumulation by removing them from the serum. Bence Jones protein precipitates most readily if the urine is concentrated, the pH is below 6, and solutes and albumin are present. 5 An alkaline diuresis should thus help to prevent cast formation, and possibly remove existing casts. Such treatment has been shown to protect mice with Bence Jones proteinuria from renal damage, reducing cast formation, and has prevented progression of renal failure in a patient with mye-lomatosis. 4